Turning Point 2023

Posted date

A selection of articles from the 2023 issue of Turning Point.

To see the entire issue of Turning Point, please download the PDF version. If you'd like to receive a print version of Turning Point in the mail, please complete this form.


Improving Cancer Care for Everyone

How Dana-Farber is spearheading new strategies to correct historical trends and disparities in cancer care and prevention

A New Era of Targeted Cancer Therapy

Antibody-drug conjugates — a kind of molecular "smart bomb" — are emerging as an important form of targeted treatment across a variety of cancers

Finding the Right Balance

How Dana-Farber researchers are helping cancer patients get the tools they need to lead fulfilling daily lives

Research With a Worldwide Reach

How Dana-Farber's environment of collaboration sparks new clinical trials and results in a far-reaching impact

How Investigator-Initiated Clinical Trials Advance Medicine

The curiosity and tenacity of individual researchers can spark unforeseen advances and breakthroughs.

Turning Point is published for supporters of the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute.

Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:

Turning Point
Dana-Farber Cancer Institute
Department of Communications
450 Brookline Ave.
Boston, MA 02215
Phone: 617-632-4090
Email: TurningPoint@dfci.harvard.edu

Request a Publication

Receive by mail the current issue of a Dana-Farber publication by completing this request form.

Request a Publication

Media Contacts

If you are a journalist and have a question about any of our stories or need more information, email media@dfci.harvard.edu or call 617-632-4090 and ask to speak to a member of the media team.

The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.